Taken together, both gain and loss of function experiments further confirmed that upregulation of Wip1 could facilitate the proliferation and aggressiveness of renal cancer cell lines in vitro, which was consistent with our data from the immunohistochemical analysis using the clinical ccRCC samples. This evidence concerns the gene PPM1D and nonpapillary renal cell carcinoma.